These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 26050379)

  • 1. The promise and peril of pre-exposure prophylaxis (PrEP): using social science to inform prep interventions among female sex workers.
    Syvertsen JL; Robertson Bazzi AM; Scheibe A; Adebajo S; Strathdee SA; Wechsberg WM
    Afr J Reprod Health; 2014 Sep; 18(3 Spec No):74-83. PubMed ID: 26050379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PrEP implementation research in Africa: what is new?
    Cowan FM; Delany-Moretlwe S; Sanders EJ; Mugo NR; Guedou FA; Alary M; Behanzin L; Mugurungi O; Bekker LG
    J Int AIDS Soc; 2016; 19(7(Suppl 6)):21101. PubMed ID: 27760680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Time to Scale Up Preexposure Prophylaxis Beyond the Highest-Risk Populations? Modeling Insights From High-Risk Women in Sub-Saharan Africa.
    Grant H; Gomez GB; Kripke K; Barnabas RV; Watts C; Medley GF; Mukandavire Z
    Sex Transm Dis; 2020 Nov; 47(11):767-777. PubMed ID: 33044426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early antiretroviral therapy and daily pre-exposure prophylaxis for HIV prevention among female sex workers in Cotonou, Benin: a prospective observational demonstration study.
    Mboup A; Béhanzin L; Guédou FA; Geraldo N; Goma-Matsétsé E; Giguère K; Aza-Gnandji M; Kessou L; Diallo M; Kêkê RK; Bachabi M; Dramane K; Geidelberg L; Cianci F; Lafrance C; Affolabi D; Diabaté S; Gagnon MP; Zannou DM; Gangbo F; Boily MC; Vickerman P; Alary M
    J Int AIDS Soc; 2018 Nov; 21(11):e25208. PubMed ID: 31291057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Awareness and Interest in HIV Pre-Exposure Prophylaxis Among Street-Based Female Sex Workers: Results from a US Context.
    Tomko C; Park JN; Allen ST; Glick J; Galai N; Decker MR; Footer KHA; Sherman SG
    AIDS Patient Care STDS; 2019 Feb; 33(2):49-57. PubMed ID: 30632769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retention in an mHealth App Aiming to Promote the Use of HIV Pre-Exposure Prophylaxis Among Female Sex Workers in Dar es Salaam, Tanzania: Prospective Cohort Study.
    Mbotwa CH; Kazaura MR; Moen K; Leshabari MT; Metta E; Mmbaga EJ
    JMIR Mhealth Uhealth; 2023 Oct; 11():e46853. PubMed ID: 37855221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effectiveness of tenofovir-based pre-exposure prophylaxis for prevention of HIV acquisition among sub-Saharan African women at high risk: a systematic review.
    Murewanhema G; Malisheni M; Takah NF
    Pan Afr Med J; 2021; 38():308. PubMed ID: 34178226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "I am still negative": Female sex workers' perspectives on uptake and use of daily pre-exposure prophylaxis for HIV prevention in South Africa.
    Eakle R; Bothma R; Bourne A; Gumede S; Motsosi K; Rees H
    PLoS One; 2019; 14(4):e0212271. PubMed ID: 30964874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rethinking HIV prevention to prepare for oral PrEP implementation for young African women.
    Celum CL; Delany-Moretlwe S; McConnell M; van Rooyen H; Bekker LG; Kurth A; Bukusi E; Desmond C; Morton J; Baeten JM
    J Int AIDS Soc; 2015; 18(4 Suppl 3):20227. PubMed ID: 26198350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MPrEP+ study protocol: a prospective cohort study assessing the feasibility and acceptability of an HIV pre-exposure prophylaxis (PrEP) strategy for male clients of female sex workers in Kisumu, Kenya.
    Mantell J; Franks J; Zerbe A; Lamb MR; Reed DM; Omollo D; Lahuerta M; Naitore D; El-Sadr WM; Agot K
    BMJ Open; 2022 Nov; 12(11):e064037. PubMed ID: 36332953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. "Whatever is in the ARVs, is Also in the PrEP" Challenges Associated With Oral Pre-exposure Prophylaxis Use Among Female Sex Workers in South Africa.
    Makhakhe NF; Sliep Y; Meyer-Weitz A
    Front Public Health; 2022; 10():691729. PubMed ID: 35784260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PrEP as a feature in the optimal landscape of combination HIV prevention in sub-Saharan Africa.
    McGillen JB; Anderson SJ; Hallett TB
    J Int AIDS Soc; 2016; 19(7(Suppl 6)):21104. PubMed ID: 27760682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV pre-exposure prophylaxis uptake, retention and adherence among female sex workers in sub-Saharan Africa: a systematic review.
    Mpirirwe R; Segawa I; Ojiambo KO; Kamacooko O; Nangendo J; Semitala FC; Kyambadde P; Kalyango JN; Kiragga A; Karamagi C; Katahoire A; Kamya M; Mujugira A
    BMJ Open; 2024 Apr; 14(4):e076545. PubMed ID: 38670600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV risk and pre-exposure prophylaxis interest among female bar workers in Dar es Salaam: cross-sectional survey.
    Harling G; Muya A; Ortblad KF; Mashasi I; Dambach P; Ulenga N; Barnhart D; Mboggo E; Oldenburg CE; Bärnighausen T; Spiegelman D
    BMJ Open; 2019 Mar; 9(3):e023272. PubMed ID: 30898799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of implementation strategies on pre-exposure prophylaxis persistence among female sex workers in South Africa: an interrupted time series study.
    Rao A; Mhlophe H; Pretorius A; Mcingana M; Mcloughlin J; Shipp L; Baral S; Hausler H; Schwartz S; Lesko C
    Lancet HIV; 2023 Dec; 10(12):e807-e815. PubMed ID: 38040479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV self-testing and oral pre-exposure prophylaxis are empowering for sex workers and their intimate partners: a qualitative study in Uganda.
    Mujugira A; Nakyanzi A; Kasiita V; Kamusiime B; Nalukwago GK; Nalumansi A; Twesigye CC; Muwonge TR; Baeten JM; Wyatt MA; Haberer JE; Ware NC
    J Int AIDS Soc; 2021 Sep; 24(9):e25782. PubMed ID: 34473405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Promise and pitfalls of pre-exposure prophylaxis for female sex workers.
    Cowan FM; Delany-Moretlwe S
    Curr Opin HIV AIDS; 2016 Jan; 11(1):27-34. PubMed ID: 26633639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating the potential impact and cost-effectiveness of dapivirine vaginal ring pre-exposure prophylaxis for HIV prevention.
    Reidy M; Gardiner E; Pretorius C; Glaubius R; Torjesen K; Kripke K
    PLoS One; 2019; 14(6):e0218710. PubMed ID: 31242240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact and cost-effectiveness of the national scale-up of HIV pre-exposure prophylaxis among female sex workers in South Africa: a modelling analysis.
    Stone J; Bothma R; Gomez GB; Eakle R; Mukandavire C; Subedar H; Fraser H; Boily MC; Schwartz S; Coetzee J; Otwombe K; Milovanovic M; Baral S; Johnson LF; Venter WDF; Rees H; Vickerman P
    J Int AIDS Soc; 2023 Feb; 26(2):e26063. PubMed ID: 36807874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acceptability of microbicidal vaginal rings and oral pre-exposure prophylaxis for HIV prevention among female sex workers in a high-prevalence US city.
    Peitzmeier SM; Tomko C; Wingo E; Sawyer A; Sherman SG; Glass N; Beyrer C; Decker MR
    AIDS Care; 2017 Nov; 29(11):1453-1457. PubMed ID: 28271718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.